Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 287-370-9 | CAS number: 85480-89-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- one-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 281 days overall
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 979
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- This study was conducted to assess the long-term effects of CP 41863 when administered continuously via the diet to Long-Evans rats at concentrations of 300, 1000 and 3000 ppm through onecomplete generation. Test substance administration to the F0 generation females (201group) was initiated at the onset of gestation and continued throughout the ensuing gestation and lactation periods. Dietary administration of CP 41863 continued to the F1 generation animals (10 males and 20 females/group) through a growth period and mating, gestation and l actation period for two successive litters.
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- [ethane-1,2-diylbis[nitrilobis(methylene)]]tetrakisphosphonic acid
- EC Number:
- 215-851-5
- EC Name:
- [ethane-1,2-diylbis[nitrilobis(methylene)]]tetrakisphosphonic acid
- Cas Number:
- 1429-50-1
- Molecular formula:
- C6H20N2O12P4
- IUPAC Name:
- {ethane-1,2-diylbis[nitrilobis(methylene)]}tetrakis(phosphonic acid)
- Reference substance name:
- Ethylenediaminetetra (methylene phosphonic acid)
- IUPAC Name:
- Ethylenediaminetetra (methylene phosphonic acid)
- Details on test material:
- Ethylenediaminetetra (methylene phosphonic acid) % active ingredient = 93.3%
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Long-Evans
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: B1 ue Spruce Farms A1 tamont, N.Y.
- Age at study initiation: (P) 15-16 weeks
- Housing:Individually in elevated stainless steel cages (except during mating).
- Diet (e.g. ad libitum):Standard laboratory diet (Purina Laboratory Chow@ 5001 )
-ad l ibitum.
- Water (e.g. ad libitum):ad libitum
- Acclimation period: 19 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C):Temperature monitored twice daily
- Humidity (%): Not stated
- Air changes (per hr):Not stated
- Photoperiod (hrs dark / hrs light):12 hour l i ght/dark cycle.
Administration / exposure
- Route of administration:
- oral: feed
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:No information
- Lot/batch no. (if required):176-18-8-B
- Purity:93.3% - Details on mating procedure:
- F0 Females: Females were p1aced w ith male rats nightly in a r a t i o of 2:l. Vaginal smears were taken early in
the morning and females were considered t o have mated if sperm and/or vaginal plug was observed. The day on which evidence of
mating was observed was defined as Day 0 of gestation.
F1 Females: One male and two females of equivalent dose l e l v e l s were caged together nightly for 15 nights or until a sign of mating (sperm and/or vaginal plug) was observed. Care was taken t o avoid brother-sister mating. The day on which evidence of mating was observed was defined as Day 0 of gestation. - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- Test substance was administered continuously , beginning Day 0 of
gestation for the F0 females and continued for the F1 males and females through the F2a and F2b
litters.
Age of F0 and initiation of test substance administration: 15-16 weeks. - Frequency of treatment:
- Daily
- Details on study schedule:
- Test substance administration of the F0 females was initiated the day signs of mating were observed (Day 0 of gestation) and continued throughout
the ensuing gestation and l actation periods. F1 offspring were separated from siblings seven days after the weaning (Day 21 of lactation) of the last litter and were randomly selected to continue as future parents ( F1 ).
F1 animals were raised to maturity and mated to produce the F2, litters . Fea pups were sacrificed, necropsied and discarded at weaning. All
F1 females were remated after a rest period of at least 14 days to produce theF2b litters . F2b pups were sacrificed and necropsied a t weaning.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
Administered in the diet
Basis:
other: 0,300,1000,3000 ppm
- No. of animals per sex per dose:
- Fo - (females) - 20/group
F1 - (males and females) - 10 M + 20 F /group - Control animals:
- yes
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
Physical observations -twice daily.For mortality and gross signs of toxicologic or pharmacologic effects. (Fo, F1 parents)
Detailed physical observations - for signs of local or systemic toxicity, pharrnacologic effects and palpation for tissue masses (Fo, F1 p a r e n t s ) :
DETAILED CLINICAL OBSERVATIONS: Yes / No / No data
- Time schedule:
BODY WEIGHT: Yes
- Mean maternal body weight during gestation and lactation; mean pup body weight recorded at days 0,4,14,21 of lactation; mean body weight recorded during F1 growth and rest periods.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes / No / No data
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data
Results and discussion
Results: P0 (first parental generation)
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- > 3 000 ppm
- Based on:
- labile/free
- Remarks:
- acid
- Sex:
- male/female
Results: F1 generation
Effect levels (F1)
- Dose descriptor:
- NOEL
- Generation:
- F1
- Effect level:
- > 3 000 ppm
- Based on:
- labile/free
- Remarks:
- acid
- Sex:
- male/female
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
F0 generation - No treatment related effects were evident in respect to growth, food consumption, reproductive-fertility, or litter examination parameters. At terminal sacrifice, the mid dose males and high dose animals had lower body weights. In the mid and high dose levels, males had higher adrenal weights both absolute and relative to body and brain weights. High dose females had higher thyroid/body and spleen/body weight ratios. however organ to brain weight ratios revealed no treatment effect in the F1 females.
Gross postmortem observations and evaluation of selected tissues from five adult F1 generation males and females of the control (Groups I and II) and high dose (Group V) groups indicated no treatment related effects.
No treatment related effects on any of the reproductive parameters. (Mating, fertility; pregnancy, parturition & survival)
Applicant's summary and conclusion
- Executive summary:
In a one generation reproductive toxicity study, the test substance was administered continuously via the diet to Long-Evans F0 generation females (20/group) at the onset of gestation and continued throughout the ensuing gestation and lactation periods. Dietary administration was continued to the F1 generation animals (10 males and 20 females /group) through a growth period and a mating, gestation and lactation period for two successive litters.
In the F0 generation, no treatment effects were evident in the low or mid dose groups. In the F1 generation, no treatment effects were observed in growth, food consumption, fertility-reproduction or litter examination parameters. At terminal sacrifice, mid dose males an high dose animals had lower body weights. In the mid and high dose levels, males had higher adrenal weights, both absolute and relative to body and brain ratios.
However in the absence of histopathological/clinical pathology examination results, it is not clear whether or not the weight change a real effect.In the absence of adverse clinical /reproductive effects for this substance it is unlikely to be of toxicological significance.
Therefore the NOAEL for reproductive effects for F0 and F1 is > 3000 ppm.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.